Jack Anders Insider Trades & Stock Holdings

Chief Financial Officer · Revolution Medicines, Inc. · Latest filing Jun 24, 2026

Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. has 3 Form 4 trades on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($3.79M), net -$3.79M. Latest filing: disposed of 20K shares of $RVMD on Jun 24, 2026 at $168.33.

Trades on file

3

Open-market bought

$0

Open-market sold

$3.79M

Net open-market

-$3.79M

Latest filing

Jun 24, 2026

All insider trades by Jack Anders

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 24, 2026	$RVMD	Sell (Open-market sale) 10b5-1	20K	$168.33	$3.37M			+10.4%	+11.5%		Chief Financial Officer		Read
Jun 24, 2026	$RVMD	Buy (Option exercise)	20K	$0	—			+10.4%	+11.5%		Chief Financial Officer		Read
Jun 16, 2026	$RVMD	Sell (Open-market sale) 10b5-1	2.72K	$156.12	$424.96K			+8.3%	+14.4%		Chief Financial Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Jack Anders traded

• $RVMD

Frequently asked questions

Has Jack Anders been buying or selling stock?

Jack Anders has 0 open-market purchases and 2 open-market sales on file, net -$3.79M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Jack Anders's latest insider trade?

disposed of 20K shares of $RVMD on Jun 24, 2026 at $168.33.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.